Singapore: Medical Charity, Medecins Sans Frontieres (MSF) has condemned the US for mounting pressure on India's new gov...
Singapore: U.S. Food and Drug Administration (FDA) has approved Novo Nordisk's Biologics License Application (BLA) for r...
Singapore: Novartis Pharmaceuticals has reported to settle its litigation with US subsidiary of India based Sun Pharmace...
Singapore: German drugmaker Bayer announced that Dr Marjin Dekkers will step down as the CEO, by the end of 2016. The fi...
Mumbai: Pharma major Lupin's subsidiary, Lupin Pharmaceuticals, has received final approval for its pregabalin capsules,...
Singapore: Tripura has become the first Indian state to announce its implementation of the country's health ministry's d...
Singapore: As a strong reaction to the import ban placed on Ranbaxy Laboratories' third manufacturing unit in India, the...
Singapore: Leading Indian generic drug maker, Ranbaxy Laboratories, along with its owners, Japan's second largest pharma...
Singapore: Soon after reports of Ranbaxy's Mohali manufacturing plant being issued a Form 483 by the US US FDA broke out...
Singapore: The US subsidiary of Japanese drug major Astellas Pharma has entered into a distribution agreement with Tecno...
Mumbai: Dr. Reddy's Laboratories, India's leading pharmaceutical company, recently launched Montelukast Sodium Tablets a...
Singapore: The South East Asian pharmaceuticals industry is forecast to witness a boost to $3.9 billion by 2016. The in...
Singapore: The police in China have made it official that four senior Chinese executives of GlaxoSmithKline have been de...
Singapore: Mayne Pharma from Australia has made a second US acquisition by buying privately-held US-based generic drugma...
Singapore: Chinese prosecutors have received more than 600,000 inquiries about bribery records involving companies or in...
Singapore: Even as police in China are investigating claims of bribery against the British drug major for bribing doctor...
Singapore: In a move that is threatening to become a high profile patent infringement suit, global biopharma company UCB...
Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent o...
